SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-149302
Filing Date
2023-05-19
Accepted
2023-05-19 16:06:55
Documents
13
Period of Report
2023-05-15
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d484910d8k.htm   iXBRL 8-K 27077
2 EX-99.1 d484910dex991.htm EX-99.1 66795
  Complete submission text file 0001193125-23-149302.txt   229962

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA amrx-20230515.xsd EX-101.SCH 2848
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE amrx-20230515_lab.xml EX-101.LAB 17236
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE amrx-20230515_pre.xml EX-101.PRE 10811
7 EXTRACTED XBRL INSTANCE DOCUMENT d484910d8k_htm.xml XML 3244
Mailing Address 400 CROSSING BOULEVARD 3RD FLOOR BRIDGEWATER NJ 08807
Business Address (908) 947-3120
Amneal Pharmaceuticals, Inc. (Filer) CIK: 0001723128 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38485 | Film No.: 23940072
SIC: 2834 Pharmaceutical Preparations